-
Mashup Score: 9Sarcoidosis - 6 day(s) ago
Sarcoidosis is an important member of the family of granulomatous lung diseases. Since its recognition in the late 19th century, sarcoidosis has been thought of as a disease of unknown cause. Over the past 20 years, this paradigm has been shifting, more rapidly in the past 10 years. Epidemiologic studies, bolstered by case reports, have provided evidence of causal associations between occupational exposure to specific agents and sarcoidosis. Pathogenesis has been more clearly defined, including the role of gene-exposure interactions.
Source: journal.chestnet.orgCategories: General Medicine News, PulmonologyTweet
-
Mashup Score: 33Diagnosis and Management of Cardiac Sarcoidosis: Key Points - American College of Cardiology - 13 day(s) ago
Thomas C. Crawford, MD, FACC
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 7Ocular Signs and Testing Most Compatible with Sarcoidosis-associated Uveitis: A Latent Class Analysis - 24 day(s) ago
This study aims to explore the potential subgroups of sarcoidosis-associated uveitis (SAU) within a multicenter cohort of uveitis participants.
Source: www.ophthalmologyscience.orgCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 5Sarcoidosis: Sisters Garrie & Sharon’s Very Different Journey - 27 day(s) ago
Meet Garrie Farrow and learn her story of living with Sarcoidosis, and the impact of her sister Sharon’s similar journey. Their story is featured in ATS Pati…
Source: www.youtube.comCategories: General Medicine News, PulmonologyTweet
-
Mashup Score: 17Efficacy and safety of mTOR inhibition in cutaneous sarcoidosis: a single-centre trial - 2 month(s) ago
Short-term treatment with systemic sirolimus might be an effective and safe treatment option for patients with persistent glucocorticoid-refractory sarcoidosis with a long-lasting disease-modulating effect. The effect of sirolimus in granulomatous inflammation should be investigated further in large, multi-centre, randomised clinical trials.
Source: www.thelancet.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 17Efficacy and safety of mTOR inhibition in cutaneous sarcoidosis: a single-centre trial - 3 month(s) ago
Short-term treatment with systemic sirolimus might be an effective and safe treatment option for patients with persistent glucocorticoid-refractory sarcoidosis with a long-lasting disease-modulating effect. The effect of sirolimus in granulomatous inflammation should be investigated further in large, multi-centre, randomised clinical trials.
Source: www.thelancet.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 0Sarcoidosis Explained - 7 month(s) ago
Frank Rivera of Stronger Than Sarcoidosis, Sarcoidosis of Long Island, and a patient himself, discusses this rare immunologic condition.
Source: CheckRare.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Optimal left ventricular ejection fraction in risk stratification of patients with cardiac sarcoidosis - 7 month(s) ago
AbstractAims. Identifying patients with cardiac sarcoidosis (CS) who are at an increased risk of sudden cardiac death (SCD) poses a clinical challenge. We sough
Source: academic.oup.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3Pri-Med | Sarcoidosis in the Lungs: What... - 8 month(s) ago
Already listened on another platform? 0.25 AMA PRA Category 1 Credits â„¢, 0.25 ABIM MOC or 0.25 AANP, including 0.25 AANP Pharm The following relevant financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute. Mridu Gulati, MD, MPH: Speaker for Boehringer Ingelheim. Advisor for CDC/NIOSH. Researcher for Boehringer Ingelheim and Bristol Myers Squibb. George A. Mensah, MD: No relevant financial relationships disclosed. Charles Vega, MD, FAAFP (Moderator):
Source: www.pri-med.comCategories: Hem/Oncs, Latest HeadlinesTweet-
.#NHLBI curriculum. #PrimaryCare: Earn CME credit via @PriMedCME podcast presented with @StopSarcoidosis on what to know about #sarcoidosis in the #lungs. #ImpSci @NIH. Speakers: Dr. George Mensah at @NIH_NHLBI & Dr. Mridu Gulati at @YaleMed. Listen here: https://t.co/BA63h3IpbS https://t.co/yzJcy9mqTp
-
-
Mashup Score: 0Sarcoidosis Patient's Cancer Misdiagnosis - 8 month(s) ago
Frank Rivera, a patient with sarcoidosis, discusses his seven-year diagnostic journey including a misdiagnosis of lung cancer.Â
Source: CheckRare.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
To spread awareness for National Sarcoidosis Day, read & share a journal CHEST® review discussing published findings regarding associations between occupational exposure to silica and silicates, World Trade Center dust/metals, and risk for #sarcoidosis: https://t.co/rxCU2sXhDP https://t.co/aK2yMTZgzt